A great business is not always investment-ready, and a funding-ready startup is not always a great business. This article explores why investors need to evaluate both Investment Quality and Funding Readiness before allocating capital, and how the Capital Readiness Score (CRS) provides a more complete measure of startup investability.

What makes a startup truly investment-worthy? The Investment Quality Score (IQS) evaluates startups across eleven critical dimensions including leadership, market opportunity, innovation, business model strength, financial health, governance, and scalability. This article explores how IQS provides a structured approach to assessing startup quality beyond valuation and fundraising metrics.

Valuation is one of the most discussed metrics in startup investing, but it is often misunderstood. A high valuation does not automatically indicate a high-quality investment opportunity. This article explores the limitations of valuation-based decision-making and explains why investors must also assess startup quality, funding readiness, and capital readiness before allocating capital.

Elevent Index is a research-driven startup assessment framework that evaluates Investment Quality, Funding Readiness, and Capital Readiness to support structured investment decision-making and capital allocation.